Rapport Therapeutics
Rapport Therapeutics, Inc. (Nasdaq: RAPP) is a clinical-stage biotechnology company headquartered in Boston, Massachusetts with research operations in San Diego, California, founded in 2022 and taken public in a $174 million IPO in June 2024. Rapport develops precision small-molecule medicines for central nervous system disorders using its proprietary RAP technology platform, which pairs human genetics with functional proteomics to identify receptor-associated proteins that confer neuroanatomical specificity — the goal being drugs that act only where the disease circuit lives rather than across the whole brain. Its lead clinical candidate, RAP-219, is a selective negative allosteric modulator of TARP-gamma-8-associated AMPA receptors in development for focal onset seizures, peripheral neuropathic pain and bipolar disorder, behind two discovery-stage nicotinic acetylcholine receptor programs targeting alpha-6 (chronic pain) and alpha-9-alpha-10 (hearing disorders). Rapport is a therapeutics developer, not a software vendor: the RAP platform is an internal discovery capability and the company publishes no developer program, no public API and no machine-readable API contract.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
API Evangelist profiles Rapport Therapeutics the way a machine reads it — 1 machine-readable artifact, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Rapport Therapeutics scores 10.7/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Why this profile is thin
Rapport Therapeutics is a clinical-stage CNS drug developer whose product is a molecule pipeline (RAP-219 plus two discovery nAChR programs); www.rapportrx.com is a seventeen-page WordPress marketing site where every contract-discovery path — /openapi.json, /swagger.json, /api-docs, /graphql, /llms.txt and all seven /.well-known/ paths — returns 404, no api/developer/docs subdomain resolves, the RAP platform is an internal discovery capability that is never exposed, and the only machine-readable surface on the domain is the CMS's default, unadvertised /wp-json/ index describing pages and posts rather than a product API.
This is an honest zero, not a gap in our research. Rapport Therapeutics does not appear to expose an API, so there is nothing here for us to index and nothing for them to fix.
What we probed
https://www.rapportrx.com/openapi.json→ HTTP 404https://www.rapportrx.com/graphql→ HTTP 404https://www.rapportrx.com/.well-known/api-catalog→ HTTP 404https://www.rapportrx.com/.well-known/agent-card.json→ HTTP 404https://www.rapportrx.com/llms.txt→ HTTP 404https://developer.rapportrx.com/→ HTTP 0https://investors.rapportrx.com/→ HTTP 0
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance. Every facet and dimension name is a link: it opens that measurement's page on APIs.io, where the rating runs across the whole catalog — the exact checks that feed it, how every profiled provider distributes on it, and who is at the top of it.
Kin Score
How this is scored →scored 2026-09-01 · rubric v0.18.0
Put this on your own site. The badge is drawn live from Rapport Therapeutics's current Kin Score — paste it once and it updates itself every time the score is recomputed. It follows your visitor's light or dark setting, and it links back here so anyone who sees it can read the full breakdown.
<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/rapport-therapeutics/"
title="Rapport Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/rapport-therapeutics.svg"
alt="Rapport Therapeutics Kin Score — API readiness rating by API Evangelist" width="150" height="150" loading="lazy">
</a>[](https://providers.apievangelist.com/providers/rapport-therapeutics/)<!-- Kin Score · API Evangelist -->
<a href="https://providers.apievangelist.com/providers/rapport-therapeutics/"
title="Rapport Therapeutics on API Evangelist — API profile and Kin Score">
<img src="https://apis.io/badge/rapport-therapeutics/card.svg"
alt="Rapport Therapeutics Kin Score — API readiness rating by API Evangelist" width="340" height="120" loading="lazy">
</a>More shapes, themes and sizes → · Score as JSON · How badges work
How we profile Rapport Therapeutics
Each block below is one kind of artifact we hold for Rapport Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Rapport Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 4
The organization behind the API
← All providers · Data indexed from github.com/api-evangelist/rapport-therapeutics · machine-readable index on apis.io
This is an independent, third-party profile of Rapport Therapeutics, published by API Evangelist. We do not operate, host, resell, or support these APIs, and we are not affiliated with or endorsed by the company unless stated above. Everything here is built from publicly available information — the company's own site, developer portal, documentation, public repositories, and the specifications it publishes for public use. Nothing is obtained by breaching a system, defeating an access control, or using credentials.
The Kin Score and Agent Readiness rating are independently calculated assessments of a company's public API artifacts, scored against a published rubric. They are not certifications, endorsements, security assessments, or audits.
Corrections, re-scores, and removal are free — no partnership or purchase required, and you do not need to justify the request. A removed company is recorded as unrated, never scored zero for having asked. Acknowledgement within one business day; removal within two.
info@apievangelist.com
·
Read the full data-sourcing policy →
On a security or compliance team? Put security in the subject line and
you will get a person, not a form — we will tell you exactly which public URLs this profile was built from.